Sertraline and rapid eye movement sleep without atonia: An 8-week, open-label study of depressed patients

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 47, Issue , 2013, Pages 85-92

  Zhang, Bin ^a   Hao, Yanli ^b   Jia, Fujun ^a   Tang, Yi ^a   Li, Xueli ^a   Liu, Wuhan ^a   Arnulf, Isabelle ^c  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Depressed patient; Rapid eye movement (REM) sleep without atonia (RSWA); REM sleep behavior disorder (RBD); Sertraline

Indexed keywords

SERTRALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG DOSE TITRATION; DRUG EFFECT; DRUG WITHDRAWAL; ELECTROMYOGRAM; FEMALE; GASTROINTESTINAL SYMPTOM; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; MUSCLE TONE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OPEN STUDY; PATIENT REFERRAL; PERIODIC LIMB MOVEMENT INDEX; POLYSOMNOGRAPHY; PSYCHOSIS; RAPID EYE MOVEMENT SLEEP WITHOUT ATONIA; REM SLEEP; SKELETAL MUSCLE; SLEEP DISORDER; SLEEP EFFICIENCY; SLEEP PARAMETERS; SLEEP TIME; SUBMENTAL MUSCLE; TIBIALIS ANTERIOR MUSCLE; TREATMENT DURATION; VIDEO POLYSOMNOGRAPHY;

5-HT; AASM-2007; AHI; AI; AMERICAN ACADEMY OF SLEEP MEDICINE 2007 VERSION; ANOVA; APNEA-HYPOPNEA INDEX; AROUSAL INDEX; BMI; BODY MASS INDEX; COMPUTED TOMOGRAPHY; CT; DA; DEPRESSED PATIENT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS FOURTH EDITION; DOPAMINERGIC; DSM-IV; ECG; ELECTROCARDIOGRAPH; ELECTROMYOGRAM; ELECTROOCULOGRAPH; EMG; EOG; EPWORTH SLEEPINESS SCALE; ESS; HAMILTON RATING SCALE FOR DEPRESSION; HRSD; MSLT; MULTIPLE SLEEP LATENCY TEST; OBSESSIVE-COMPULSIVE DISORDER; OBSTRUCTIVE SLEEP APNEA; OCD; ONE-WAY ANALYSIS OF VARIANCE; OSA; PARKINSON'S DISORDER; PD; PERIODIC LIMB MOVEMENT DURING SLEEP; PERIODIC LIMB MOVEMENT INDEX; PITTSBURGH SLEEP QUALITY INDEX; PLMI; PLMS; POLYSOMNOGRAM; PSG; PSQI; RAPID EYE MOVEMENT; RAPID EYE MOVEMENT (REM) SLEEP WITHOUT ATONIA (RSWA); REM; REM SLEEP BEHAVIOR DISORDER (RBD); REM SLEEP WITHOUT ATONIA; RESTLESS LEGS SYNDROME; RLS; RSWA; SCID-2; SE; SELECTIVE SEROTONIN REUPTAKE INHIBITORS; SEROTONIN; SERTRALINE; SL; SLEEP EFFICIENCY; SLEEP LATENCY; SSRI; TESS-S; TESS-T; THE SECOND VERSION OF THE STRUCTURED CLINICAL INTERVIEW FOR DSM-IV AXIS I DISORDERS; TOTAL RECORDING TIME; TOTAL SLEEP TIME; TREATMENT EMERGENT SYMPTOM SCALE-SEVERITY; TREATMENT EMERGENT SYMPTOM SCALE-TREATMENT; TRT; TST; VIDEO-POLYSOMNOGRAPHY; VPSG; WAKE AFTER SLEEP ONSET; WASO;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; REM SLEEP BEHAVIOR DISORDER; RETROSPECTIVE STUDIES; SERTRALINE; TIME FACTORS; VIDEO RECORDING; YOUNG ADULT;

EID: 84884192584     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2013.08.010     Document Type: Article

References (35)

1. AASM International classification of sleep disorders: diagnostic and coding manual 2005, American Academy of Sleep Medicine, Westchester, Illinois.
2. Agnew H.W., Webb W.B., Williams R.L. The first night effect: an EEG study of sleep. Psychophysiology 1966, 2:263-266.
3. Arnulf I. REM sleep behavior disorder: motor manifestations and pathophysiology. Mov Disord 2012, 27:677-689.
4. Bental E., Lavie P., Sharf B. Severe hypermotility during sleep in treatment of cataplexy with clomipramine. Isr J Med Sci 1979, 15:607-609.
5. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28:193-213.
6. Carskadon M.A., Dement W.C., Mitler M.M., Roth T., Westbrook P.R., Keenan S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986, 9:519-524.
7. First M.B., S.R., Williams J.B.W., Gibbon M., Williams J.W.B. User's guide for the structured clinical interview for DSM-IV axis I disorders: SCID-II clinician version 1996, American Psychiatric Association.
8. Frauscher B., Iranzo A., Gaig C., Gschliesser V., Guaita M., Raffelseder V., et al. Normative EMG values during REM sleep for the diagnosis of REM sleep behavior disorder. Sleep 2012, 35:835-847.
9. Gagnon J.F., Postuma R.B., Montplaisir J. Update on the pharmacology of REM sleep behavior disorder. Neurology 2006, 67:742-747.
10. Guilleminault C., Raynal D., Takahashi S., Carskadon M., Dement W. Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride. Acta Neurol Scand 1976, 54:71-87.
11. Guy W. ECDEU assessment manual for psychopharmacology, revised 1976, Rockville, DEW, USA.
12. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
13. Hoque R., Chesson A.L. Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. J Clin Sleep Med 2010, 6:79-83.
14. Iber C., A.-I.S., Cheeson A., Quan SF for the academy of sleep medicine The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications 2007, American Academy of Sleep Medicine, Westchester, Illinois.
15. Iranzo A., Santamaria J., Rye D.B., Valldeoriola F., Marti M.J., Munoz E., et al. Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD. Neurology 2005, 65:247-252.
16. Iranzo A., Santamaria J., Tolosa E. The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases. Sleep Med Rev 2009, 13:385-401.
17. Jindal R.D., Friedman E.S., Berman S.R., Fasiczka A.L., Howland R.H., Thase M.E. Effects of sertraline on sleep architecture in patients with depression. J Clin Psychopharmacol 2003, 23:540-548.
18. Johns M.W. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992, 15:376-381.
19. Kugaya A., Seneca N.M., Snyder P.J., Williams S.A., Malison R.T., Baldwin R.M., et al. Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology 2003, 28:413-420.
20. Lam S.P., Fong S.Y., Ho C.K., Yu M.W., Wing Y.K. Parasomnia among psychiatric outpatients: a clinical, epidemiologic, cross-sectional study. J Clin Psychiatry 2008, 69:1374-1382.
21. Lapierre O., Montplaisir J. Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology 1992, 42:1371-1374.
22. Mcnamara P., Auerbach S., Johnson P., Harris E., Doros G. Impact of REM sleep on distortions of self-concept, mood and memory in depressed/anxious participants. J Affect Disord 2010, 122:198-207.
23. Mendelson W.B. Are periodic leg movements associated with clinical sleep disturbance?. Sleep 1996, 19:219-223.
24. Montplaisir J., Gagnon J.F., Fantini M.L., Postuma R.B., Dauvilliers Y., Desautels A., et al. Polysomnographic diagnosis of idiopathic REM sleep behavior disorder. Mov Disord 2010, 25:2044-2051.
25. Murray D.J., Lopez A.D. The global burden of disease: a comprehensive assessment of morality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 1996, Harvard School of Public Health in behalf of the World Health Organization and the Word Bank, Cambridge, MA.
26. Nash J.R., Wilson S.J., Potokar J.P., Nutt D.J. Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism. Neurology 2003, 61:1161. [author reply 1161].
27. Onofrj M., Luciano A.L., Thomas A., Iacono D., D'andreamatteo G. Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism. Neurology 2003, 60:113-115.
28. Pace-schott E.F., Gersh T., Silvestri R., Stickgold R., Salzman C., Hobson J.A. SSRI treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects. J Sleep Res 2001, 10:129-142.
29. Rush A.J., Giles D.E., Jarrett R.B., Feldman-Koffler F., Debus J.R., Weissenburger J., et al. Reduced REM latency predicts response to tricyclic medication in depressed outpatients. Biol Psychiatry 1989, 26:61-72.
30. Schenck C.H. Clinical and research implications of a validated polysomnographic scoring method for REM sleep behavior disorder. Sleep 2005, 28:917-919.
31. Schenck C.H., Mahowald M.W. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16years after its formal identification in SLEEP. Sleep 2002, 25:120-138.
32. Schenck C.H., Mahowald M.W., Kim S.W., O'connor K.A., Hurwitz T.D. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep 1992, 15:226-235.
33. Siegel J.M. The stuff dreams are made of: anatomical substrates of REM sleep. Nat Neurosci 2006, 9:721-722.
34. Winkelman J.W., James L. Serotonergic antidepressants are associated with REM sleep without atonia. Sleep 2004, 27:317-321.
35. Zhang B., Li X.L., Zhou P. The effect of selective serotonin reuptake inhibitor on electromyography of rapid eye movement sleep in depressive patient. Chin J Psychiatry 2010, 43:201-205.